当期报告
Kodiak Sciences(KOD)05-16 04:15
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-060455 Act: 34 Size: 254 KB 网页链接
简介:Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司,专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301,一种用抗体生物聚合物共轭平台或ABC平台构建的生物疗法,旨在维持眼组织中有效和有效的药物水平。Kodiak Sciences Inc.认为,如果获得批准,KSI-301有可能成为湿性年龄相关性黄斑变性,湿性AMD和糖尿病性视网膜病变或DR的重要抗VEGF治疗。KSI-301及其ABC平台是在Kodiak开发的,他们拥有这些资产的全球权利,包括KSI-301的物质专利保护组成。Kodiak Sciences Inc.已经应用他们的ABC平台开发了除KSI-301之外的其他候选产品,包括KSI-501,他们的双特异性抗IL-6/VEGF生物共轭物。
今开:2.23 | 昨收:2.2 |
最高:2.39 | 最低:2.22 |
涨停价: | 跌停价: |
总市值:123457125 |
Kodiak Sciences(KOD)05-16 04:15
$Kodiak Sciences(KOD)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-060455 Act: 34 Size: 254 KB 网页链接
Kodiak Sciences(KOD)04-24 04:35
$Kodiak Sciences(KOD)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-107101 Act: 34 Size: 1 MB 网页链接
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018658 Size: 5 KB 网页链接
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018663 Size: 5 KB 网页链接
Kodiak Sciences(KOD)07-03 04:55
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080612 Size: 22 KB 网页链接
Kodiak Sciences(KOD)06-07 04:15
$Kodiak Sciences(KOD)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-156056 Act: 34 Size: 148 KB 网页链接
Kodiak Sciences(KOD)06-14 04:45
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016682 Size: 9 KB 网页链接
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018661 Size: 5 KB 网页链接
Kodiak Sciences(KOD)07-02 06:25
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018655 Size: 5 KB 网页链接
Kodiak Sciences(KOD)04-24 04:25
$Kodiak Sciences(KOD)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-107064 Act: 34 Size: 3 MB 网页链接
网络异常请稍后再试2023-07-26 12:47
$Kodiak Sciences(KOD)$ 眼病对于副作用的容忍度是非常非常小的。
KSI-301是基于ABC平台开发的一款抗VEGF药物,旨在延长药物在眼部组织的作用时间,从而改善视网膜血管疾病患者的预后,并为糖尿病眼病患者提供早期治疗和预防视力丧失的方案。尽管KSI-301显示出了治疗潜力,但Kodiak还是决定终...查看全文
牛唐2023-07-25 12:55
$Kodiak Sciences(KOD)$ 及时锁利,不赌数据。$阿里巴巴-SW(09988)$ $小鹏汽车-W(09868)$查看全文
SeekingBiotech2023-07-24 21:52
$Kodiak Sciences(KOD)$
KOD Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
GLEAM and GLIMMER studies did not meet their primary efficacy endpoints. 又一个错失终点nAM...查看全文
不入流资讯2023-07-24 19:50
$Kodiak Sciences(KOD)$ Kodiak Sciences plummets 47% after scraping development of eye disorder drug查看全文
产业链观察2023-07-24 18:08
#药闻简讯# $Kodiak Sciences(KOD)$ 公布 Tarcocimab Tedromer 治疗新生血管性老年黄斑变性和糖尿病性黄斑水肿的 3 期研究的初步结果。
GLEAM和GLIMMER研究未达到主要疗效终点#临床研究失败#查看全文
牛唐2023-06-12 22:32
$Kodiak Sciences(KOD)$ 从建仓到加仓,80%+的收益。$百度(BIDU)$ $理想汽车(LI)$查看全文
产业链观察2022-08-08 19:55
药闻▶2022年8月8日,$Kodiak Sciences(KOD)$ 宣布,其新型抗体生物聚合物结合物Tarcocimab tedromer(KSI-301;tarcocimab)的BEACON 3期研究达到了主要终点,即与阿夫利贝特相比,视网膜静脉闭塞导致的黄斑水肿患者在第24周的视力变化不低于基线。Tarcocimab还显示出强大的解剖学反...查看全文
牛唐2022-06-02 11:21
医药板块速评(2022.06.01)
本期内容提示:
1、9月暂停加息预期打破,大盘后续走势如何看?
2、多家公司市值低于现金,哪些烟蒂股有反转机会?
3、$Kodiak Sciences(KOD)$ 积极股东介入,是否有反转机会?
$特斯拉(TSLA)$ $哔哩哔哩(BILI)$查看全文
牛唐2022-02-24 22:45
医药板块速评(2022.02.23)
本期内容提示:
1、大盘暴跌,如何搭建做空工具组合?
2、大跌之下,哪些医药股有抄底机会?
3、$Kodiak Sciences(KOD)$ 暴跌,知名机构重仓,是否有抄底机会?
$百济神州-U(SH688235)$ $药明康德(SH603259)$查看全文
PracticeOnly2022-02-24 10:27
$Kodiak Sciences(KOD)$ ,其实只说明了一点,生物医药不确定性太大了,不是每个人都能承受得起动辄20%甚至50%以上的跌幅。如果真想好了从中淘金,最好分散点。当然,异常自信的除外。不要自信心爆棚,但投资结果又很糟糕,那就不是“自信”是“自负”了。查看全文
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-080612 Size: 22 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018665 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018655 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018658 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018663 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-018661 Size: 5 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-017449 Size: 11 KB 网页链接
$Kodiak Sciences(KOD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016682 Size: 9 KB 网页链接
$Kodiak Sciences(KOD)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-156056 Act: 34 Size: 148 KB 网页链接
$Kodiak Sciences(KOD)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060483 Act: 34 Size: 4 MB 网页链接